Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Organon & Co. (OGN) has a Wall Street consensus price target of $6.50, based on estimates from 8 covering analysts. With the stock currently trading at $7.29, this represents a potential downside of -10.8%. The company has a market capitalization of $1.90B.
Analyst price targets range from a low of $5.00 to a high of $8.00, representing a 46% spread in expectations. The median target of $6.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, OGN trades at a trailing P/E of 10.1x and forward P/E of 2.1x. Analysts expect EPS to grow +386.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $16.50, with bear and bull scenarios of $16.15 and $68.82 respectively. Model confidence stands at 34/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how OGN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonOGN's consensus price target is $6.5, -10.8% below the current price of $7.29. The 8 analysts tracking OGN see downside risk at present valuations.
OGN has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $6.5 implies -10.8% downside from current levels.
With a forward P/E of 2.0857x, OGN trades at a relatively low valuation. The consensus target of $6.5 implies -10.8% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $8 for OGN, while the most conservative target is $5. The consensus of $6.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $69 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
OGN is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month OGN stock forecast based on 8 Wall Street analysts shows a consensus price target of $6.5, with estimates ranging from $5 (bear case) to $8 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $17, with bear/bull scenarios of $16/$69.
Our quantitative valuation model calculates OGN's fair value at $17 (base case), with a bear case of $16 and bull case of $69. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 34/100.
OGN trades at a forward P/E ratio of 2.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on OGN, with 3 Sell ratings and a price target of $6.5 (-10.8% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
OGN analyst price targets range from $5 to $8, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6.5 consensus represents the middle ground. Our model's $16-$69 range provides an independent fundamental perspective.